Dynavax Technologies Corporation's IPO

Dynavax Technologies Corporation raised a round of funding on February 19, 2004. Investors include Public.

Dynavax Technologies Corporation discovers, develops, and intends to commercialize innovative TLR9 agonist-based products to treat and prevent infectious diseases, allergies, cancer, and chronic infla…

Articles about Dynavax Technologies Corporation's IPO: